Other
2028
Amgen 2028 decreased by 20.0% to $2.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.3%, from $3.70B to $2.80B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
How to read this metric
A declining trend in these annual projections indicates that the bank's historical acquisition costs are being successfully absorbed.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2028. It reflects the...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_398565Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.40B | $2.40B | $2.50B | $2.50B | $2.40B | $2.50B | $2.50B | $2.50B | $3.90B | $3.90B | $3.90B | $3.70B | $3.70B | $3.50B | $2.80B |
| QoQ Change | — | +0.0% | +4.2% | +0.0% | -4.0% | +4.2% | +0.0% | +0.0% | +56.0% | +0.0% | +0.0% | -5.1% | +0.0% | -5.4% | -20.0% |
| YoY Change | — | — | — | +4.2% | +0.0% | +0.0% | +0.0% | +4.2% | +56.0% | +56.0% | +56.0% | -5.1% | -5.1% | -10.3% | -24.3% |
Range$2.40B – $3.90B
CAGR+4.5%
Avg YoY Growth+11.0%
Median YoY Growth+0.0%
Current Streak2 quarters decline
2028 at Other Companies
Frequently Asked Questions
- What is Amgen's 2028?
- Amgen (AMGN) reported 2028 of $2.80B in Q1 2026.
- How has Amgen's 2028 changed year-over-year?
- Amgen's 2028 decreased by 24.3% year-over-year, from $3.70B to $2.80B.
- What does 2028 mean?
- The expected non-cash expense for acquired intangible assets in the year 2028.